Related Experiment Videos
Tenascin-C induced signaling in cancer.
Gertraud Orend1, Ruth Chiquet-Ehrismann
1Department of Clinical and Biological Sciences, Institute of Biochemistry and Genetics, Center for Biomedicine, DKBW, University of Basel, Mattenstrasse 28, 4058 Basel, Switzerland. gertraud.orend@unibas.ch
Cancer Letters
|April 25, 2006
Summary
Tenascin-C, a protein in tumors, promotes cancer growth and spread. Studying its role in knockout mice could lead to new cancer therapies targeting this extracellular matrix molecule.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Tenascin-C is an extracellular matrix protein overexpressed in many solid tumors.
- High tenascin-C levels correlate with poor prognosis and reduced disease-free survival in cancer patients.
- Its function in the tumor microenvironment is critical for cancer progression.
Purpose of the Study:
- To investigate the role of tenascin-C in tumor initiation and progression.
- To elucidate the signaling mechanisms by which tenascin-C influences cancer development.
- To explore the therapeutic potential of targeting tenascin-C in cancer treatment.
Main Methods:
- Review of existing literature on tenascin-C and cancer.
- Analysis of signaling pathways affected by tenascin-C.
- Examination of phenotypes in tenascin-C knock-out mouse models.
Main Results:
- Tenascin-C promotes malignant transformation, proliferation, angiogenesis, and metastasis.
- It also contributes to the evasion of tumor immunosurveillance.
- Knock-out mouse models provide insights into tenascin-C's specific functions in tumorigenesis.
Conclusions:
- Tenascin-C is a key driver of tumor progression through multiple mechanisms.
- Understanding tenascin-C's role is crucial for developing novel cancer therapies.
- Targeting tenascin-C may offer a promising strategy for improving cancer treatment outcomes.